Latest Jazz Pharmaceuticals (JAZZ) Headlines A
Post# of 76
Posted On: 03/12/2014 10:46:06 PM
Latest Jazz Pharmaceuticals (JAZZ) Headlines
A Brief History Of 21st Century Stock Leadership
at Investor's Business Daily - Wed Mar 12, 5:24PM CDT
Here's a short list of short lists of leading stocks. In May 2003, Investor's Business Daily launched the IBD 100. The feature each week zeroed in on 100 leading stocks -- the best of the best among leaders, aimed at saving investors time by culling...
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 3.97% Gain
Comtex SmarTrend(R) - Wed Mar 12, 3:57PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $150.36 to a high of $159.88. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $157.23 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
How To Invest: Seek Stock Ideas In Sector Leaders
at Investor's Business Daily - Tue Mar 11, 4:23PM CDT
Every great trade begins with a great idea. While there's a wealth of places in IBD to get great ideas for your watch list, one feature that investors must check out is Sector Leaders. Published today on Page B1, the Sector Leaders are the top-rated...
Jazz Pharmaceuticals Earnings In Retrospect: Down 11.3% in the Last 13 Days (JAZZ)
Comtex SmarTrend(R) - Mon Mar 10, 7:58AM CDT
When Jazz Pharmaceuticals (NASDAQ:JAZZ) reported earnings 13 days ago on February 25th, 2014, analysts, on average, expected the company to report earnings of $1.78 on sales of $237.5 million. The company actually reported EPS of $1.72 on sales of $235.8 million, missing EPS estimates by $0.06 and missing revenue estimates by $1.7 million. Since the company's report, shares of Jazz Pharmaceuticals have fallen from $174.98 to $155.24, representing a loss of 11.3% in the past 13 days.
Nasdaq Lags As Stock Market Closes Lower
at Investor's Business Daily - Fri Mar 07, 3:28PM CST
Stocks closed mixed as a better-than-expected jobs report failed to hold the market's interest. Indexes opened higher after the Labor Department reported an increase of 175,000 jobs in February, while the unemployment rate edged up to 6.7%. But the...
Stocks Open Higher, Turn Mixed After Employment Report
at Investor's Business Daily - Fri Mar 07, 9:31AM CST
Stocks opened higher Friday, then backtracked to mixed terrain as drugmakers and some leading stocks added drag in early trade. The Dow Jones industrial average remained ahead 0.4%. The S&P 500 was up 0.2% and the Nasdaq slipped 0.2%. Celgene (CELG),...
Stock Market Closes Mixed; Ambarella Tops Expectations
at Investor's Business Daily - Thu Mar 06, 4:00PM CST
Stocks closed mixed Thursday, and after the bell Ambarella (AMBA) topped profit expectations. Ambarella, a maker of video chips, reported a 27% jump in sales to $40 million for the January-ended quarter. Adjusted earnings of 26 cents a share were...
Stock Market Closes Mixed; Medical Leaders Drop
at Investor's Business Daily - Thu Mar 06, 3:13PM CST
Stocks closed mixed Thursday as the medical sector, one of the market's bulwarks, came under some selling. The Dow Jones industrial average led with a 0.4% gain, while the S&P 500 added 0.2% and the Nasdaq fell 0.2%. Volume fell across the board,...
Insider Trading Alert - IP, CYBX And JAZZ Traded By Insiders
at The Street - Thu Mar 06, 1:00PM CST
Stocks with insider trader activity include IP, CYBX and JAZZ
MacroGenics Appoints Matthew Fust to Its Board of Directors
GlobeNewswire - Thu Mar 06, 6:09AM CST
MacroGenics, Inc. (Nasdaq:MGNX) today announced that its Board of Directors is increasing its size from seven to eight members and that Matthew Fust has been appointed to fill the vacancy. Mr. Fust joins the Board and becomes Chairman of its Audit Committee, effective immediately. Mr. Fust will serve as a Class II Director, with Class II having a term expiring at the annual meeting of stockholders to be held in 2015.
Gentium S.p.A. Announces Decision to Voluntarily Delist American Depositary Shares from The NASDAQ Global Market
GlobeNewswire - Wed Mar 05, 1:50PM CST
Gentium S.p.A. (Nasdaq:GENT), a Jazz Pharmaceuticals company, today announced that it has notified the NASDAQ Stock Market of its intention to voluntarily delist its American Depositary Shares (ADSs) from The NASDAQ Global Market.
New Government in Italy: How Will It Affect These Italian ADRs?
Louie Grint, The Motley Fool - Motley Fool - Tue Mar 04, 1:38PM CST
As you probably heard, after the breakup of the government coalition that was ruling Italy, Matteo Renzi became the new prime minister in the country. Well, he just took office on Saturday and designated Pier Carlo Padoan, chief economist at the...
The Zacks Analyst Blog Highlights:Cummins, STRATTEC Security, Allison Transmission Holdings, Gentex and TiVo
PR Newswire - Tue Mar 04, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Cummins Inc. (NYSE:CMI-Free Report), STRATTEC Security Corp. (Nasdaq:STRT-Free Report), Allison Transmission Holdings, Inc. (NYSE:ALSN-Free Report), Gentex Corp. (Nasdaq:GNTX-Free Report) and TiVo Inc. (Nasdaq:TIVO-Free Report).
SmarTrend Watching for Potential Rebound in Shares of Jazz Pharmaceuticals After 8.81% Loss
Comtex SmarTrend(R) - Fri Feb 28, 4:31PM CST
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $151.30 to a high of $166.00. Yesterday, the shares fell 8.8%, which took the trading range below the 3-day low of $157.57 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Leaders Take Hits; Nasdaq Reverses After Early Strength
at Investor's Business Daily - Fri Feb 28, 3:25PM CST
The Dow Jones industrial average and S&P 500 ended higher Friday, but the Nasdaq reversed early gains. There was no specific news that fueled the Nasdaq's sell-off, but growing unrest in Ukraine continued to dominate the headlines. The S&P 500 and...
Major Indexes Hold Near New Milestones; MasTec Surges
at Investor's Business Daily - Fri Feb 28, 12:28PM CST
Stocks continued to hold near their session highs in afternoon trading Friday. The Dow Jones industrial average and the S&P 500 were up 0.7% each while the Nasdaq rose 0.4%. Despite mixed economic data this morning, the Nasdaq hit a nearly 14-year...
Drugmakers Like Jazz, Shire Key To Europe's Recovery
at Investor's Business Daily - Wed Feb 26, 5:37PM CST
London's FTSE 100 and Frankfurt's DAX both eased on Wednesday after rising to record highs this week. In Paris, the CAC-40 also took a breather after bumping a six-year high Monday. Europe's leading indexes are basically in line with U.S. market...
Uptrend Call Working As Jazz Pharmaceuticals Stock Rises 3.8% (JAZZ)
Comtex SmarTrend(R) - Wed Feb 26, 5:16PM CST
SmarTrend identified an Uptrend for Jazz Pharmaceuticals (NASDAQ:JAZZ) on January 30th, 2014 at $156.10. In approximately 4 weeks, Jazz Pharmaceuticals has returned 3.82% as of today's recent price of $162.06.
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March
PR Newswire Europe - Wed Feb 26, 5:04PM CST
Jazz Pharmaceuticals plc today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences.
A Brief History Of 21st Century Stock Leadership
at Investor's Business Daily - Wed Mar 12, 5:24PM CDT
Here's a short list of short lists of leading stocks. In May 2003, Investor's Business Daily launched the IBD 100. The feature each week zeroed in on 100 leading stocks -- the best of the best among leaders, aimed at saving investors time by culling...
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 3.97% Gain
Comtex SmarTrend(R) - Wed Mar 12, 3:57PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $150.36 to a high of $159.88. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $157.23 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
How To Invest: Seek Stock Ideas In Sector Leaders
at Investor's Business Daily - Tue Mar 11, 4:23PM CDT
Every great trade begins with a great idea. While there's a wealth of places in IBD to get great ideas for your watch list, one feature that investors must check out is Sector Leaders. Published today on Page B1, the Sector Leaders are the top-rated...
Jazz Pharmaceuticals Earnings In Retrospect: Down 11.3% in the Last 13 Days (JAZZ)
Comtex SmarTrend(R) - Mon Mar 10, 7:58AM CDT
When Jazz Pharmaceuticals (NASDAQ:JAZZ) reported earnings 13 days ago on February 25th, 2014, analysts, on average, expected the company to report earnings of $1.78 on sales of $237.5 million. The company actually reported EPS of $1.72 on sales of $235.8 million, missing EPS estimates by $0.06 and missing revenue estimates by $1.7 million. Since the company's report, shares of Jazz Pharmaceuticals have fallen from $174.98 to $155.24, representing a loss of 11.3% in the past 13 days.
Nasdaq Lags As Stock Market Closes Lower
at Investor's Business Daily - Fri Mar 07, 3:28PM CST
Stocks closed mixed as a better-than-expected jobs report failed to hold the market's interest. Indexes opened higher after the Labor Department reported an increase of 175,000 jobs in February, while the unemployment rate edged up to 6.7%. But the...
Stocks Open Higher, Turn Mixed After Employment Report
at Investor's Business Daily - Fri Mar 07, 9:31AM CST
Stocks opened higher Friday, then backtracked to mixed terrain as drugmakers and some leading stocks added drag in early trade. The Dow Jones industrial average remained ahead 0.4%. The S&P 500 was up 0.2% and the Nasdaq slipped 0.2%. Celgene (CELG),...
Stock Market Closes Mixed; Ambarella Tops Expectations
at Investor's Business Daily - Thu Mar 06, 4:00PM CST
Stocks closed mixed Thursday, and after the bell Ambarella (AMBA) topped profit expectations. Ambarella, a maker of video chips, reported a 27% jump in sales to $40 million for the January-ended quarter. Adjusted earnings of 26 cents a share were...
Stock Market Closes Mixed; Medical Leaders Drop
at Investor's Business Daily - Thu Mar 06, 3:13PM CST
Stocks closed mixed Thursday as the medical sector, one of the market's bulwarks, came under some selling. The Dow Jones industrial average led with a 0.4% gain, while the S&P 500 added 0.2% and the Nasdaq fell 0.2%. Volume fell across the board,...
Insider Trading Alert - IP, CYBX And JAZZ Traded By Insiders
at The Street - Thu Mar 06, 1:00PM CST
Stocks with insider trader activity include IP, CYBX and JAZZ
MacroGenics Appoints Matthew Fust to Its Board of Directors
GlobeNewswire - Thu Mar 06, 6:09AM CST
MacroGenics, Inc. (Nasdaq:MGNX) today announced that its Board of Directors is increasing its size from seven to eight members and that Matthew Fust has been appointed to fill the vacancy. Mr. Fust joins the Board and becomes Chairman of its Audit Committee, effective immediately. Mr. Fust will serve as a Class II Director, with Class II having a term expiring at the annual meeting of stockholders to be held in 2015.
Gentium S.p.A. Announces Decision to Voluntarily Delist American Depositary Shares from The NASDAQ Global Market
GlobeNewswire - Wed Mar 05, 1:50PM CST
Gentium S.p.A. (Nasdaq:GENT), a Jazz Pharmaceuticals company, today announced that it has notified the NASDAQ Stock Market of its intention to voluntarily delist its American Depositary Shares (ADSs) from The NASDAQ Global Market.
New Government in Italy: How Will It Affect These Italian ADRs?
Louie Grint, The Motley Fool - Motley Fool - Tue Mar 04, 1:38PM CST
As you probably heard, after the breakup of the government coalition that was ruling Italy, Matteo Renzi became the new prime minister in the country. Well, he just took office on Saturday and designated Pier Carlo Padoan, chief economist at the...
The Zacks Analyst Blog Highlights:Cummins, STRATTEC Security, Allison Transmission Holdings, Gentex and TiVo
PR Newswire - Tue Mar 04, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Cummins Inc. (NYSE:CMI-Free Report), STRATTEC Security Corp. (Nasdaq:STRT-Free Report), Allison Transmission Holdings, Inc. (NYSE:ALSN-Free Report), Gentex Corp. (Nasdaq:GNTX-Free Report) and TiVo Inc. (Nasdaq:TIVO-Free Report).
SmarTrend Watching for Potential Rebound in Shares of Jazz Pharmaceuticals After 8.81% Loss
Comtex SmarTrend(R) - Fri Feb 28, 4:31PM CST
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $151.30 to a high of $166.00. Yesterday, the shares fell 8.8%, which took the trading range below the 3-day low of $157.57 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Leaders Take Hits; Nasdaq Reverses After Early Strength
at Investor's Business Daily - Fri Feb 28, 3:25PM CST
The Dow Jones industrial average and S&P 500 ended higher Friday, but the Nasdaq reversed early gains. There was no specific news that fueled the Nasdaq's sell-off, but growing unrest in Ukraine continued to dominate the headlines. The S&P 500 and...
Major Indexes Hold Near New Milestones; MasTec Surges
at Investor's Business Daily - Fri Feb 28, 12:28PM CST
Stocks continued to hold near their session highs in afternoon trading Friday. The Dow Jones industrial average and the S&P 500 were up 0.7% each while the Nasdaq rose 0.4%. Despite mixed economic data this morning, the Nasdaq hit a nearly 14-year...
Drugmakers Like Jazz, Shire Key To Europe's Recovery
at Investor's Business Daily - Wed Feb 26, 5:37PM CST
London's FTSE 100 and Frankfurt's DAX both eased on Wednesday after rising to record highs this week. In Paris, the CAC-40 also took a breather after bumping a six-year high Monday. Europe's leading indexes are basically in line with U.S. market...
Uptrend Call Working As Jazz Pharmaceuticals Stock Rises 3.8% (JAZZ)
Comtex SmarTrend(R) - Wed Feb 26, 5:16PM CST
SmarTrend identified an Uptrend for Jazz Pharmaceuticals (NASDAQ:JAZZ) on January 30th, 2014 at $156.10. In approximately 4 weeks, Jazz Pharmaceuticals has returned 3.82% as of today's recent price of $162.06.
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March
PR Newswire Europe - Wed Feb 26, 5:04PM CST
Jazz Pharmaceuticals plc today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences.
(0)
(0)Jazz Pharmaceuticals (JAZZ) Stock Research Links
Scroll down for more posts ▼